Pathology, Complications, and Prognosis of Type 1 Diabetes (T1D)
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Endocrinology and Metabolism Research".
Deadline for manuscript submissions: 31 March 2026
Special Issue Editor
Interests: pharmacoepidemiology; type 1 diabetes; cardiovascular outcomes; health services research; medication adherence; pharmacoeconomics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Type 1 diabetes (T1D) is a chronic autoimmune disease that results in lifelong dependence on insulin therapy and predisposes individuals to a wide range of acute and chronic complications. Despite major advances in glucose monitoring, insulin delivery systems, and adjunctive therapies, the burden of complications such as cardiovascular disease, kidney failure, neuropathy, retinopathy, and psychiatric comorbidities remains high. These complications significantly affect prognosis, quality of life, and health care utilization, underscoring the urgent need for deeper understanding and improved management strategies.
This Special Issue will collate original research articles, comprehensive reviews, and perspectives that address the biological mechanisms, clinical trajectories, and outcomes of T1D complications. We especially welcome studies that integrate real-world data, translational approaches, and innovative therapeutic or preventive strategies. By highlighting the interplay between disease pathology, complications, and prognosis, this Special Issue will advance knowledge that can inform precision medicine and improve long-term outcomes for individuals living with T1D.
We look forward to receiving your contributions.
Dr. Tadesse Melaku Abegaz
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- type 1 diabetes
- complications
- prognosis
- cardiovascular disease
- neuropathy
- retinopathy
- nephropathy
- disease mechanisms
- clinical outcomes
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
